KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Raw Materials (2016 - 2025)

Historic Raw Materials for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $13.7 million.

  • CareDx's Raw Materials rose 4188.66% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year increase of 4188.66%. This contributed to the annual value of $10.9 million for FY2024, which is 253.25% up from last year.
  • Per CareDx's latest filing, its Raw Materials stood at $13.7 million for Q3 2025, which was up 4188.66% from $13.9 million recorded in Q2 2025.
  • Over the past 5 years, CareDx's Raw Materials peaked at $13.9 million during Q2 2025, and registered a low of $8.1 million during Q1 2021.
  • Moreover, its 5-year median value for Raw Materials was $10.6 million (2023), whereas its average is $11.1 million.
  • In the last 5 years, CareDx's Raw Materials soared by 36453.2% in 2021 and then tumbled by 1440.57% in 2023.
  • Over the past 5 years, CareDx's Raw Materials (Quarter) stood at $10.4 million in 2021, then increased by 14.52% to $12.0 million in 2022, then dropped by 11.22% to $10.6 million in 2023, then rose by 2.53% to $10.9 million in 2024, then increased by 25.41% to $13.7 million in 2025.
  • Its Raw Materials was $13.7 million in Q3 2025, compared to $13.9 million in Q2 2025 and $13.7 million in Q1 2025.